ASCOLT finds no overall adjuvant aspirin benefit in colorectal cancer, but meta-analysis links improved disease-free survival to PIK3CA exon 9/20 mutations.
News|Articles|June 3, 2025
Men’s Health Month 2025: Spotlight on Prostate Cancer, Lifelong Health
Author(s)Brooke McCormick
Fact checked by: Skylar Jeremias
Men’s Health Month 2025 encourages men to adopt preventive care and healthy lifestyle habits to improve overall health outcomes.
Advertisement
Advertisement
Men’s Health Month highlights the importance of preventive care and healthy habits for men, with a renewed focus on prostate cancer awareness following former President Joe Biden’s recent
Related to this article
Five August FDA approvals introduced novel therapies across vaccines, neurology, oncology, myeloma, and dermatomyositis, despite some regulatory pushback.
Christos Vaklavas, MD, discussed barriers limiting rural oncology access and challenges to adopting resource-intensive therapies.
FDA cut required monitoring for tarlatamab’s first 2 doses from 22-24 hours to 6-8 hours, easing a barrier to community cancer care.
Shiven B. Patel, MD, MBA, shares strategies for closing biomarker testing gaps, including among patients with non–small cell lung cancer.
Real-world DLBCL data show Incyte’s tafasitamab matches L-MIND responses across diverse Non-Hodgkin lymphoma patients, per Cardinal Health review.
AACR urges Congress to protect NIH/NCI funding amid a fight over a contested OMB grantmaking rule.
Patient factors and access barriers are reshaping treatment sequencing and individualized care for relapsed multiple myeloma, Amandeep Godara, MBBS, said.
Advertisement
Advertisement